BARROW HANLEY MEWHINNEY & STRAUSS LLCBARROW HANLEY MEWHINNEY & STRAUSS LLC

Institutional investor · Portfolio as of Q4 2018

Top Holdings348 positions

Checking export access…
Activity:

DOLLAR GEN CORP NEW

14.2M$1.5B3.0%$97.150.00%
1 qtr
First report
0

PFIZER INC

31.1M$1.4B2.7%$28.590.00%
1 qtr
First report
0

WELLS FARGO CO NEW

28.5M$1.3B2.6%$37.340.00%
1 qtr
First report
0

LOWES COS INC

14.2M$1.3B2.6%$79.920.00%
1 qtr
First report
0

ORACLE CORP

28.2M$1.3B2.5%$40.300.00%
1 qtr
First report
0

CVS HEALTH CORP

19.2M$1.3B2.5%$51.030.00%
1 qtr
First report
0

COMCAST CORP NEW

36.8M$1.3B2.5%$25.390.00%
1 qtr
First report
0

JOHNSON CTLS INTL PLC

41.4M$1.2B2.4%$25.310.00%
1 qtr
First report
0

AIR PRODS & CHEMS INC

7.5M$1.2B2.3%$132.870.00%
1 qtr
First report
0

PHILLIPS 66

13.6M$1.2B2.3%$63.580.00%
1 qtr
First report
0

QUALCOMM INC

20.2M$1.1B2.2%$47.310.00%
1 qtr
First report
0
DODOWDPDelisted

DOWDUPONT INC COM

20.6M$1.1B2.2%——
1 qtr
First report
0

AMERICAN EXPRESS CO

11.6M$1.1B2.2%$86.060.00%
1 qtr
First report
0

JPMORGAN CHASE & CO.

11.3M$1.1B2.2%$79.100.00%
1 qtr
First report
0

US BANCORP DEL

23.9M$1.1B2.1%$33.890.00%
1 qtr
First report
0
10.3M$1.1B2.1%——
1 qtr
First report
0

MEDTRONIC PLC

11.9M$1.1B2.1%$73.070.00%
1 qtr
First report
0

DOMINION ENERGY INC

15M$1.1B2.1%$53.810.00%
1 qtr
First report
0

CONOCOPHILLIPS

16.5M$1B2.0%$48.440.00%
1 qtr
First report
0
SNYSNY
ADR

SANOFI

22.5M$975.3M1.9%$31.250.00%
1 qtr
First report
0
$51B
AUM
348
Positions
Q4 2018
Filing
HI score · 2.0/5
Quarterly 13F Value Change
Not enough history yet
Activity profile
Q4'18

First report: nothing earlier to compare

Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
<1Q100%1-4Q0%1-2Y0%2Y+0%

BARROW HANLEY MEWHINNEY & STRAUSS LLC manages $51B across 348 positions as of Q4 2018. Top holdings: DG (3.0%), PFE (2.7%), WFC (2.6%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 2/5.0.

Q4 2018 Summary

First quarter we have for this fund: 348 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $51.0B across 348 positions.

Top holdings by portfolio weight

Total AUM$51B
DG3.01%
PFE2.66%
WFC2.57%
LOW2.57%
ORCL2.49%
CVS2.46%
CMCSA2.45%
JCI2.40%
APD2.35%
PSX2.30%
Other2.25%

Portfolio allocation by GICS sector

Sectors11
Financial Services17.96%
Healthcare15.71%
Energy11.68%
Unknown10.61%
Technology9.34%
Industrials8.54%
Consumer Defensive7.39%
Consumer Cyclical6.11%
Utilities5.14%
Communication Services3.96%
Other3.55%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Financial Services, Healthcare, Energy
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(2.0 / 5.0)
Holdings P&L59
Conviction35
Concentration35
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
KDPKDPKEURIG DR PEPPER INC
Q2 2025 → Q2 2026+3.4M shares+$82.1M
4Q
UNHUNHUNITEDHEALTH GROUP INC
Q3 2025 → Q2 2026+459,544 shares+$294.9M
3Q
GFFGFFGRIFFON CORP
Q4 2025 → Q2 2026+81 shares+$9,268
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used